Delos Reyes, Macaria R.
HRN: 21-82-62 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/31/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/31/2022
09/06/2022
IV
500mg
Q8h
Obstructive Jaundice Sec To Choledocholithiasis On Top Of Cholecystitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes